INDICATION:

For the prophylaxis and treatment of infections caused by Erythromycin-sensitive organisms. Erythromycin has been shown to have in-vitro activity against the following micro-organisms: Gram positive cocci: Staphylococci and Streptococci.

Haemophilus influenzae, L-forms, Neisseria, Mycoplasma pneumoniae, Legionella pneumophila, Branhamella catarrhalis, Bordetella pertussis Corynebacterium diphtheriae (as an adjunct to antitoxin), Treponema pallidum, Chlamydia trachomatis, Ureaplasma urealytica, Clostridia, Campylobacter.

Clinical infications:

1. Upper respiratory tract infections: Tonsillitis, peritonsillar abscess, pharyngitis, laryngitis, sinusitis, secondary infections in influenza and common colds.

2. Lower respiratory tract infections: Tracheitis, acute and chronic bronchitis, pneumonia (lobar pneumonia, bronchopneumonia, primary atypical pneumonia), bronchiectasis, Legionnaire's disease.

3. Ear infections: Otitis media and otitis externa, mastoiditis.

4. Eye infections: Blepharitis.

5. Oral/dental infections: Gingivitis, Vincent's angina.

6. Skin and soft tissue infections: Boils and carbuncles, paronychia, abscesses, ustular acne, impetigo, cellulitis, erysipelas.

7. Gastro-intestinal infections: cholecystitis, staphylococcal enterocolitis.

8. Prophylaxis: pre- and post- operative trauma, burns, rheumatic fever.

9. Other infections: osteomyelitis, urethritis, gonorrhoea, syphilis, lymphogranuloma venereum, diphtheria, prostatitis, scarlet fever.

If you are a distributor, please inquire with us about product registration, importing and/or marketing our products in your country or region.